发明名称 |
Compuestos derivados de 1,2,4-triazol; composicion farmaceutica; procedimiento de preparacion de procursores de los mismos y el uso como moduladores del transporte nuclear en el tratamiento de enfermedades tales como cancer. |
摘要 |
The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula I: or a pharmaceutically acceptable salt thereof, wherein the values and alternative values for the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity. |
申请公布号 |
CL2014000225(A1) |
申请公布日期 |
2014.12.05 |
申请号 |
CL20140000225 |
申请日期 |
2014.01.29 |
申请人 |
KARYOPHARM THERAPEUTICS INC. |
发明人 |
SANDANAYAKA VINCENT P;SHACHAM SHARON;SHECHTER SHARON;MCCAULEY DILARA |
分类号 |
C07D249/08;A61K31/497;A61P35/00;C07D401/12 |
主分类号 |
C07D249/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|